During the past decade, Rheumapraxis an der Hase conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumapraxis an der Hase" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rheumapraxis an der Hase" are "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Rheumapraxis an der Hase" in a lesser frequency.

Most popular intervention types in "Rheumapraxis an der Hase" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Tocilizumab" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheumapraxis an der Hase" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rheumapraxis an der Hase". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rheumapraxis an der Hase, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumapraxis an der Hase, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".